Enforcement radar
Real enforcement — not just rule changes
Recalls and enforcement actions hitting GLP-1 and compounded products. If the pharmacy or outsourcing facility your med spa sources from lands here, that’s a patient-safety and liability problem today — not a rule that might change. Monitoring, not legal advice.
- CRITICALRECALL2026-06-12
FTC Files Contempt Motion Against Amare Global and Three Individuals Over Unsubstantiated Health Claims
FTC targets deceptive health claims affecting aesthetic practices.
What to do: Review all marketing materials for accuracy and ensure that any health claims made are properly substantiated. Consider conducting a compliance audit to align with FTC guidelines.
FTC Enforcementprimary source ↗ - CRITICALRECALL2026-05-27
FDA recall (Class II): Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, …
FDA recalls contaminated Liraglutide Injection; check your inventory!
What to do: Immediately check supplier and lot numbers for Liraglutide Injection. Quarantine any affected products and notify patients as necessary.
FDA Enforcementprimary source ↗ - CAUTIONRECALL2026-04-22
FDA recall (Class II): Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Bea…
FDA recalls semaglutide compound over sterility issues.
What to do: Immediately check your supplier for affected lot numbers and quarantine any products. Notify and monitor patients who may have received the recalled compound.
FDA Enforcementprimary source ↗ - CRITICALRECALL2026-03-11
FDA recall (Class II): Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106-02; c) 10g, NDC 843…
FDA recalls specific compounded GLP-1 products due to quality issues.
What to do: Immediately check your supplier for affected lot numbers and quarantine any recalled products. Notify and monitor patients who may have been administered these products.
FDA Enforcementprimary source ↗ - CRITICALRECALL2026-03-11
FDA recall (Class II): Tirzepatide Inj, 15mg x 4, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, …
FDA recalls Tirzepatide Inj over sterility concerns; check your stock!
What to do: Verify your supplier and lot numbers against the recall notice. Quarantine any affected product immediately and inform patients who may have received this treatment.
FDA Enforcementprimary source ↗ - CAUTIONRECALL2026-03-11
FDA recall (Class II): Tirzepatide Inj, 10mg, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC …
FDA recalls Tirzepatide injection over sterility issues.
What to do: Check your supplier for the Tirzepatide lot numbers and quarantine any related products. Notify and monitor patients who may have received this injection.
FDA Enforcementprimary source ↗ - CAUTIONRECALL2026-03-11
FDA recall (Class II): Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106-02; c) 10g, NDC 843…
Important recall on compounded Semaglutide products affecting med spas.
What to do: Check your supplier for the specific lot numbers listed in the recall. Quarantine any affected products immediately and notify patients who may have received these treatments.
FDA Enforcementprimary source ↗ - CRITICALRECALL2026-03-11
FDA recall (Class II): Semaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061,…
FDA recalls Semaglutide for sterility issues—act now!
What to do: Check your suppliers for the affected lot number and quarantine any impacted products. Additionally, notify patients who received treatments using this GLP-1 and monitor them for any adverse effects.
FDA Enforcementprimary source ↗ - CAUTIONRECALL2026-03-11
FDA recall (Class II): Semaglutide Inj, 2mg x 10, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, …
FDA recalls compounded GLP-1 product over sterility concerns.
What to do: Check your inventory for the recalled lot number and quarantine any affected products. Notify and monitor patients who may have received this product.
FDA Enforcementprimary source ↗ - CAUTIONRECALL2026-01-28
FDA device recall (Class II): Brand Name: LEASEIR Product Name: LEASEIR MHR XCELL Model/Catalog Number: MHR 110-b Software Version: 1.5.0.0 Product D…
Leaseir MHR Xcell laser recalled for safety issues.
What to do: Check if you operate the Leaseir MHR Xcell model and lot. If affected, cease use, contact the manufacturer, and monitor patients accordingly.
FDA Device Recallprimary source ↗ - CRITICALRECALL2026-01-07
FDA recall (Class II): Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880…
FDA recalls Wegovy; med spas must check supplies!
What to do: Review your supplier and lot numbers against the recall notice. Quarantine any affected products and notify patients if they have received this medication.
FDA Enforcementprimary source ↗ - CRITICALRECALL2026-01-07
FDA recall (Class II): Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 B…
FDA recalls Wegovy due to safety concerns; med spas must act.
What to do: Check your inventory for the affected lot numbers and immediately quarantine any recalled products. Notify your patients and monitor for any adverse effects related to the use of this product.
FDA Enforcementprimary source ↗ - CAUTIONRECALL2025-11-05
FDA recall (Class II): Semaglutide Injection, 8mg/3.2mL (2.5 mg/mL), 3.2mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 J…
FDA recalls Semaglutide injection due to sterility issues.
What to do: Verify your supplier and lot numbers against the FDA recall notice. Quarantine any affected products and notify patients as necessary.
FDA Enforcementprimary source ↗ - CAUTIONRECALL2025-11-05
FDA recall (Class II): Semaglutide Injection, 12.5/5mL (2.5 mg/mL), 5mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeff…
FDA recalls GLP-1 injection over sterility concerns.
What to do: Verify supplier information and check lot numbers against the recall list. Quarantine affected products and notify any patients who may have received this injection.
FDA Enforcementprimary source ↗ - CAUTIONRECALL2025-11-05
FDA recall (Class II): Semaglutide Injection, 5 mg/2 mL (2.5 mg/mL), 2mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jef…
FDA recalls GLP-1 product; take immediate action.
What to do: Check your supplier for the specific lot numbers of the recalled product. Quarantine any affected stock and notify patients who may have received this GLP-1 injection.
FDA Enforcementprimary source ↗ - CAUTIONRECALL2025-11-05
FDA recall (Class II): Semaglutide Injection, 10 mg/4 mL (2.5 mg/mL), 4mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Je…
FDA recalls Semaglutide injection over sterility issues; take action!
What to do: Check your supplier for the specific lot numbers of the recalled product. Quarantine any affected product and notify patients if they received this injection.
FDA Enforcementprimary source ↗ - CAUTIONRECALL2025-11-05
FDA recall (Class II): Semaglutide Injection, 6mg/2.4mL (2.5 mg/mL), 2.4mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 J…
FDA recalls Semaglutide injection due to sterility concerns.
What to do: Check your supplier for the recalled lot numbers and quarantine any affected products. Notify and monitor patients who may have received this product to ensure their safety.
FDA Enforcementprimary source ↗ - CRITICALRECALL2025-11-05
FDA recall (Class II): Semaglutide Injection, 2.5mg/1mL (2.5 mg/mL), 1mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jef…
Urgent: FDA recalls compounded semaglutide injection.
What to do: Review your supplies for the recalled lot numbers and quarantine any affected products. Notify patients who may have received this injection and monitor for any adverse effects.
FDA Enforcementprimary source ↗ - CAUTIONRECALL2025-11-05
FDA recall (Class II): Tirzepatide Injection, 27 mg/3 mL (9 mg/mL), 3mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeff…
Urgent FDA recall of Tirzepatide Injection impacts med spas.
What to do: Check your supplier for the affected lot numbers and quarantine any product from this batch. Notify and monitor patients who have received this injection to ensure their safety.
FDA Enforcementprimary source ↗ - CAUTIONRECALL2025-10-15
FDA recall (Class II): Semaglutide for Injection, a) 20 mg b) 20 mg/mL, 10 mL Multi-Dose Vials, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca R…
FDA recalls semaglutide over sterility issues; check your stock!
What to do: Immediately verify your supplier and lot numbers against the FDA recall. Quarantine any affected products and notify your patients who may be impacted.
FDA Enforcementprimary source ↗ - CAUTIONRECALL2025-10-15
FDA recall (Class II): Tirzepatide, 60mg/10 mL for Injection, 10mL vial lyophilized, all presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 20…
Important FDA recall on GLP-1 compounded product—act now!
What to do: Check your supplier for the specific lot numbers of the affected product. Quarantine any affected products and notify patients who may have received this treatment.
FDA Enforcementprimary source ↗ - CAUTIONRECALL2025-10-15
FDA recall (Class II): Semaglutide with B12 for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton…
FDA recalls GLP-1 product over sterility issues.
What to do: Review your inventory for any GenoGenix GLP-1 products and check lot numbers against the recall notice. Quarantine any affected products and notify your patients of potential risks.
FDA Enforcementprimary source ↗ - CAUTIONRECALL2025-09-10
FDA recall (Class II): Semaglutide, 2.5 mg/mL injection, 4 mL, Boothwyn Pharmacy
Urgent: GLP-1 injection recall for med spas sourcing compounded products.
What to do: Check the supplier and lot numbers for the recalled product, quarantine any affected stock, and notify or monitor patients who may have received it.
FDA Enforcementprimary source ↗ - CRITICALRECALL2025-09-10
FDA recall (Class II): Semaglutide, 2.5 mg/mL injection, 0.8 mL, Boothwyn Pharmacy
Med spas must act on the GLP-1 product recall now!
What to do: Immediately check your supplier for the affected product's lot numbers. Quarantine any inventory from Boothwyn Pharmacy and notify patients if they have received this product.
FDA Enforcementprimary source ↗ - CRITICALRECALL2025-09-10
FDA recall (Class II): Semaglutide, 2.5 mg/mL injection, 2 mL., Boothwyn Pharmacy
FDA recalls compounded GLP-1 product for being subpotent.
What to do: Check all supplier and lot numbers against the recall list. Quarantine any affected products and notify patients currently receiving treatment with this compound.
FDA Enforcementprimary source ↗ - CRITICALRECALL2025-08-13
FDA recall (Class II): Tirzepatide + Niacinamide 11.24 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile,…
FDA recalls compounded GLP-1 product over safety issues.
What to do: Check supplier and lot numbers for the recalled product, quarantine any affected stock, and notify patients who may have received it.
FDA Enforcementprimary source ↗ - CAUTIONRECALL2025-08-13
FDA recall (Class II): Semaglutide +Cyanocobalamin 1.5 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile…
FDA recalls compounded GLP-1 product; take immediate action!
What to do: Check the supplier and lot numbers of your GLP-1 products to identify any potentially affected stock. Quarantine the recalled product and notify your patients to monitor for any adverse effects.
FDA Enforcementprimary source ↗ - CAUTIONRECALL2025-08-13
FDA recall (Class II): Semaglutide + Cyanocobalamin injection solution, 2.21 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) s…
Stay informed: GLP-1 injectable recall may affect your practice.
What to do: Check your supplier and verify lot numbers immediately. Quarantine any affected products and notify/monitor your patients as necessary.
FDA Enforcementprimary source ↗ - CRITICALRECALL2025-08-13
FDA recall (Class II): Semaglutide + Cyanocobalamin 0.88 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Steri…
Ongoing recall of compounded GLP-1 product: take action now.
What to do: Check supplier and lot numbers for this affected GLP-1 product immediately. Quarantine any affected products and notify patients who may have received it.
FDA Enforcementprimary source ↗ - CAUTIONRECALL2025-08-13
FDA recall (Class II): Semaglutide + Cyanocobalamin 0.22 mg + 0.25mg/0.5 ml Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Steri…
Alert: GLP-1 product recall due to processing issues.
What to do: Check your supplier and lot numbers against the FDA recall list immediately. Quarantine any affected products and notify your patients who may have received this compound.
FDA Enforcementprimary source ↗ - CAUTIONRECALL2025-08-13
FDA recall (Class II): Semaglutide + Cyanocobalamin 0.44 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Steri…
Important recall for compounded GLP-1 products impacts med spas.
What to do: Check all supplier lot numbers against the recall list and quarantine any affected products. Notify and monitor your patients who may have received this product.
FDA Enforcementprimary source ↗ - CRITICALRECALL2025-08-13
FDA recall (Class II): Semaglutide + Cyanocobalamin 2.67 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Steri…
FDA recalls compounded GLP-1 product; check your stock now!
What to do: Verify your supplier and lot numbers against the recall notice. Quarantine any affected products and notify patients who may have been administered this product about the recall.
FDA Enforcementprimary source ↗ - CAUTIONRECALL2025-08-13
FDA recall (Class II): Tirzepatide + Niacinamide 4.4 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2…
FDA recalls a GLP-1 product; check your supply immediately.
What to do: Immediately check your supplier and lot numbers for this product. Quarantine any affected stock and reach out to patients for monitoring.
FDA Enforcementprimary source ↗ - CRITICALRECALL2025-08-13
FDA recall (Class II): Tirzepatide + Niacinamide 2.2 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2…
FDA recalls compounded GLP-1 product due to safety concerns.
What to do: Check your inventory against the recalled product lot numbers and quarantine any affected vials. Notify and monitor patients who have received this product for any adverse effects.
FDA Enforcementprimary source ↗ - CRITICALRECALL2025-08-13
FDA recall (Class II): Tirzepatide + Niacinamide 16.6 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, …
Important recall for GLP-1 products; take immediate action.
What to do: Verify supplier information and lot numbers against the recall notice. Quarantine any identified products and alert affected patients to monitor for adverse effects.
FDA Enforcementprimary source ↗ - CAUTIONRECALL2025-08-13
FDA recall (Class II): Tirzepatide + Niacinamide 6.6 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2…
Important FDA recall for compounded GLP-1 product impacts med spas.
What to do: Check supplier and lot numbers for the recalled product immediately. Quarantine any affected inventory and inform patients who may have been treated with it.
FDA Enforcementprimary source ↗ - CRITICALRECALL2025-08-13
FDA recall (Class II): Tirzepatide + Niacinamide 8.8 mg + 1.0mg/0.5 ml Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2…
Important recall of GLP-1 compounded product—act now!
What to do: Check your supplier records and verify lot numbers against the recall. Quarantine any affected products immediately and notify patients about the recall status.
FDA Enforcementprimary source ↗ - CAUTIONRECALL2025-08-13
FDA recall (Class II): Tirzepatide + Niacinamide 13.2 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, …
FDA recalls compounded GLP-1 product due to processing controls issue.
What to do: Immediately verify all supplier information and lot numbers for this product. Quarantine any affected stock and notify patients who may have received it.
FDA Enforcementprimary source ↗ - CAUTIONRECALL2025-07-02
FDA recall (Class II): Tirzepatide Injections, 10mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewo…
FDA recalls Tirzepatide due to sterility concerns - take action now!
What to do: Check your supplier for affected lot numbers and quarantine any products from those lots. Notify and monitor patients who may have received these injections.
FDA Enforcementprimary source ↗ - CAUTIONRECALL2025-07-02
FDA recall (Class II): Tirzepatide Injections, 20mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewo…
FDA recalls Tirzepatide for sterility issues; take action now.
What to do: Check your supplier and product lot numbers against the recall. Quarantine any affected products and inform patients who may have received these injections.
FDA Enforcementprimary source ↗ - CAUTIONRECALL2025-07-02
FDA recall (Class II): Semaglutide, 5 mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112
FDA recalls compounded GLP-1 product over sterility issues.
What to do: Check your supplier for affected lot numbers and quarantine any products involved. Notify patients who may have received this product and monitor them for any adverse effects.
FDA Enforcementprimary source ↗ - CAUTIONRECALL2025-07-02
FDA recall (Class II): Tirzepatide/Cyanocobalamin Injectable, 30mg/1mg/mL (15mg/0.5mg/0.5mL), pre-filled syringe, Thrive Health Solutions, 88 …
FDA recalls GLP-1 product due to sterility concerns.
What to do: Immediately check your inventory for the recalled product and verify lot numbers against the FDA's recall notice. Quarantine any affected product and notify your patients who may have received it.
FDA Enforcementprimary source ↗ - CRITICALRECALL2025-07-02
FDA recall (Class II): Semaglutide/Cyanocobalamin Injectable, 5mg/1mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Su…
FDA recalls compounded GLP-1 product for sterility issues.
What to do: Check your supplier for the affected lot numbers and immediately quarantine any product from that lot. Notify and monitor your patients who may have received this product.
FDA Enforcementprimary source ↗ - CRITICALRECALL2025-07-02
FDA recall (Class II): Tirzepatide Injections, 30mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewo…
FDA recalls Tirzepatide injections; action needed now.
What to do: Check your supplier for affected lot numbers and quarantine any Tirzepatide injections in stock. Notify and monitor patients who may have received this product.
FDA Enforcementprimary source ↗ - CRITICALRECALL2025-07-02
FDA recall (Class II): Tirzepatide/Cyanocobalamin Injectable, 15mg/1mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, S…
Recall alert: Check your GLP-1 injectable supplies now!
What to do: Immediately check your inventory for the affected lot numbers and quarantine any affected products. Notify patients who may have received this product and monitor for any adverse effects.
FDA Enforcementprimary source ↗ - CRITICALRECALL2025-07-02
FDA recall (Class II): Semaglutide, 2.5 mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80…
FDA recalls GLP-1 product over sterility issues.
What to do: Check your supplier and lot numbers for the recalled product immediately. Quarantine affected products and notify any patients who received the injection.
FDA Enforcementprimary source ↗ - CRITICALRECALL2025-05-07
FDA recall (Class II): Wegovy (semaglutide) injection, 2.4 mg/0.75 mL, 4 Single-Dose Prefilled Pens per Carton, For Subcutaneous Use Only, Rx …
Urgent recall of Wegovy due to temperature abuse risks.
What to do: Check your supplier and lot numbers against the recall list, quarantine any affected products, and notify patients who may have received them of the situation.
FDA Enforcementprimary source ↗
Want this watched for your states + the full radar? Claim founding access →